tiprankstipranks

Jon Saxe Insider Profile

4 Followers
Jon Saxe, Director at Sciclone Pharmaceuticals, holds 55.75K shares in VistaGen Therapeutics (Ticker: VTGN), holds 177.81K shares in Durect (Ticker: DRRX), holds 105.00K shares in Sciclone Pharmaceuticals (Ticker: SCLN). Most recently, Jon Saxe Bought ― shares of VistaGen Therapeutics on Mar 22, 2021 for an estimated value of 3.75K.
tipranks
Jon Saxe

Jon Saxe
Sciclone Pharmaceuticals (SCLN)
Director

Ranked #118 out of 97,825 Corporate Insiders

Profitable Transactions

75%
9 out of 12 Profitable Transactions

Average Return

+132.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$493K
51.67%
48.33%
A breakdown of Jon Saxe's holdings

Insider Roles

VistaGen Therapeutics
(VTGN)
Director
Durect
(DRRX)
Director
Roles that Jon Saxe holds in companies

Most Profitable Insider Trade

Stock:
VistaGen Therapeutics
(VTGN)
Rating:Informative Buy
Date:Aug 24, 2020 - Aug 24, 2021
Return:+364.00%
The most profitable trade made by Jon Saxe

Jon Saxe's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SCLN
Sciclone Pharmaceuticals
Oct 16, 2017
Uninformative Sell
1.51M
$1.17M
Durect
Jun 11, 2019
Director
Informative Buy
13.61K
$238.27K
VistaGen Therapeutics
Mar 22, 2021
Director
Informative Buy
3.75K
$254.78K
PDLI
PDL BioPharma
$1.04M
INSV
Insite Vision
$12.84K
List of latest transactions for each holding click on a transaction to see Jon Saxe's performance on stock

Jon Saxe insider profile FAQ

What is the percentage of profitable transactions made by Jon Saxe?
The percentage of profitable transactions made by Jon Saxe is 75%.
    What is the average return per transaction made by Jon Saxe?
    The average return per transaction made by Jon Saxe is 132.60%.
      What stocks does Jon Saxe hold?
      Jon Saxe holds: SCLN, DRRX, VTGN, PDLI, INSV stocks.
        What was Jon Saxe’s latest transaction?
        Jon Saxe latest transaction was an Informative Buy of $3.75K.
          What was Jon Saxe's most profitable transaction?
          Jon Saxe’s most profitable transaction was an Informative Buy of VTGN stock on August 24, 2020. The return on the trade was 364.00%.
            What is Jon Saxe's role in Sciclone Pharmaceuticals?
            Jon Saxe's role in Sciclone Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.